Skip to main navigation Skip to search Skip to main content

Development of CRISPR/dCas9-Effector Systems to Address Fibrosis in Muscle Wasting Disorders

  • James March

Research output: Thesis › Doctoral Thesis

Original languageEnglish
QualificationPh.D.
Awarding Institution
  • Royal Holloway, University of London
Supervisors/Advisors
  • Popplewell, Linda, Supervisor
Thesis sponsors
Award date1 Dec 2021
Publication statusUnpublished - 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • Fibrosis
  • Muscle wasting disorders
  • CRISPR/dCas9

Cite this